Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Robyn M. Scherber, Iván Álvarez‐Twöse et al.|NEJM Evidence|2023Cited by 74
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Peter Valent, Massimiliano Bonifacio et al.|Leukemia|2021Cited by 55
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E. Kennedy, Hanneke Oude Elberink, Cecelia Perkins et al.|Blood Advances|2022Cited by 39
Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic MastocytosisJason Gotlib, Andreas Reiter, Juliana Schwaab et al.|The Journal of Allergy and Clinical Immunology In Practice|2022Cited by 20